Islam Elkholi
iselkholi.bsky.social
Islam Elkholi
@iselkholi.bsky.social
MD, PhD|Oncology Research Fellow, McGill U.| Metastasis, Dormancy & Targeted Therapies|Writing|Coffee|Jazz/blues |🇪🇬➡️🇨🇦 Views are my own.
I ask the editor upfront (before accepting) if they are willing to wait until a specific date. If they agree, good for all and they know when my review is actually coming in.
October 17, 2025 at 1:12 PM
Different residency positions are also sponsored h1b, which means hospitals/universities would have to pay 100k/sponsored resident!
September 20, 2025 at 5:09 PM
I actually have a habit of sharing this paper with new students on the appreciation of society journals:
id.elsevier.com/as/authoriza...
My 100th JBC paper
Nobel laureate Aziz Sancar writes about his decades-long relationship with the Journal of Biological Chemistry. Since 1984, he has published 100 papers in JBC, including this “Reflections.”
id.elsevier.com
August 13, 2025 at 9:23 PM
I still prefer society journals here and all in for this. But the reality is that hiring committees for example might not value society journals (impact factor driven) -dipping my toes in the PI job market here.
The illusion of « elite » science has taken over.
August 13, 2025 at 2:08 PM
Congrats Julio and all involved. Big step
August 12, 2025 at 5:14 PM
- Asking a nonexpert (outsider) feedback is always helpful. This helped me streamline 2 successful apps that I don’t think would have been viewed the same.

- knowing the audience. À cancer focused committee is different from a diverse molecular biology one for eg.

No memes this time! 😊
August 6, 2025 at 1:08 PM
Thank you Steve! Hope you would enjoy the read!!
May 28, 2025 at 1:32 AM
A big thank you to all the co-authors and collaborators on this study for their contributions to bring this to the finish line! @standrapela.bsky.social
@gomeslab.bsky.social
@jaguirreghisolab.bsky.social
And the majority not on BlueSky!
May 27, 2025 at 1:39 PM
⭐ We also provide three datasets to be mined by the BC metastasis research community: RNA-Seq, WGS, and CRISPR screens on the 4T1 and 4T07 cells.
May 27, 2025 at 1:39 PM
⭐ Our data suggest that targeting PIK3C3 activity relocalize the lysosomes from the cell periphery to the perinuclear region leading to lower mTORC1 activity in BC cells.
May 27, 2025 at 1:39 PM
Thank you, Julio for all the insights, support and mentorship through this project!
May 20, 2025 at 2:33 AM
Yes!
March 29, 2025 at 12:16 PM